Development of vaccine for COVID-19 by Sanofi and GlaxoSmithKline (GSK)

Author Details
Author (Corporate)
Publication Date 2020
Content Type


Information and reports on the development of a vaccine to tackle the COVID-19 (coronavirus) pandemic by the pharmaceutical companies Sanofi and GlaxoSmithKline (GSK).

Further information:

Sanofi and GSK announced on 14 April 2020 they had signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies.

The joint venture announced on 29 July 2020 they had agreed to supply the United Kingdom with up to 60 million doses of the potential vaccine. This was followed by an announcement by the European Commission on 31 July that exploratory talks had been concluded with Sanofi-GSK to also purchase the potential vaccine,  in the context of its EU Strategy for COVID-19 vaccines. The contractual framework would be in place for the purchase of 300 million doses on behalf of the European Union's Member States, once a vaccine was proven to be safe and effective against the virus. An agreement was also reached with the United States for the provision of a vaccine.

Related Links
The Guardian, 14/04/2020: GSK and Sanofi join forces to work on coronavirus vaccine
The Local (France), 14/05/2020: France slams pharma giant Sanofi for saying US will get first access to coronavirus vaccine
Reuters, 23/06/2020: Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Bloomberg, 17/07/2020: EU, Sanofi Talks on Covid-19 Vaccine Aim for Supply Next Year
Times of Malta, 29/07/2020: UK signs up for Sanofi-GSK coronavirus vaccine
BBC News, 29/07/2020: Coronavirus vaccine: UK signs deal with GSK and Sanofi
The Independent (UK), 29/07/2020: Coronavirus vaccine: Government signs new deal with Sanofi and GSK for 60m doses of potential jab
Euronews, 31/07/2020: Coronavirus: EU says it struck deal with Sanofi for 300 million doses of potential COVID-19 vaccine
Forbes, 31/07/2020: U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 Vaccine
Politico, 31/07/2020: U.S. government awards $2.1B to Sanofi-GSK coronavirus vaccine
Deutsche Welle, 01/08/2020: EU strikes deal with Sanofi for supply of potential COVID-19 vaccine
RFI News, 01/08/2020: EU to buy 300 million doses of France's Sanofi's potential Covid-19 vaccine
RTL News, 02/08/2020: Sanofi, GSK reach virus vaccine deals with US, EU

Sanofi: Sanofi’s Response in the Fight against COVID-19
GSK: Resource Centre: GSK actions to support the global response to COVID-19
Sanofi: Press Release, 14/04/2020: Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
GSK: Resource Centre, 14/04/2020: Sanofi and GSK join forces to fight COVID-19
United Kingdom Government: Department of Business: Press Release, 29/07/2020: Government further boosts chances of UK receiving COVID-19 vaccine
European Commission: Press Release, 31/07/2020: Coronavirus: Commission concludes talks to secure future coronavirus vaccine for Europeans
GSK: Press Release, 31/07/2020: Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

Subject Categories
Subject Tags
International Organisations